The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease
Authors
Keywords
-
Journal
ANNALS OF HEMATOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-03
DOI
10.1007/s00277-023-05501-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pancreatic involvement in Erdheim-Chester disease: a case report and review of the literature
- (2022) Jia-wen Dai et al. BMC GASTROENTEROLOGY
- Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis
- (2021) Jia Chen et al. LEUKEMIA
- Histiocytic disorders
- (2021) Kenneth L. McClain et al. Nature Reviews Disease Primers
- Erdheim-Chester disease
- (2020) Julien Haroche et al. BLOOD
- Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era
- (2020) Gaurav Goyal et al. BLOOD
- The triptych of mixed histiocytosis: a systematic review of 105 cases and proposed clinical classification
- (2020) Arturo Bonometti et al. LEUKEMIA & LYMPHOMA
- Central nervous system involvement in Erdheim-Chester disease: An observational cohort study
- (2020) Fleur Cohen Aubart et al. NEUROLOGY
- Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim–Chester disease
- (2019) Xin-xin Cao et al. Orphanet Journal of Rare Diseases
- Efficacy of MEK inhibition in patients with histiocytic neoplasms
- (2019) Eli L. Diamond et al. NATURE
- Successful treatment of central nervous system involved Erdheim–Chester disease by intermediate-dose cytarabine as first-line therapy
- (2019) Ji-Nuo Wang et al. ACTA ONCOLOGICA
- Phenotypes and survival in Erdheim-Chester disease: Results from a 165-patient cohort
- (2018) Fleur Cohen-Aubart et al. AMERICAN JOURNAL OF HEMATOLOGY
- Prognostic factors of Erdheim-Chester Disease: A nationwide survey in Japan
- (2018) Takashi Toya et al. HAEMATOLOGICA
- Prognostic factors of Erdheim-Chester Disease: A nationwide survey in Japan
- (2018) Takashi Toya et al. HAEMATOLOGICA
- Vemurafenib for BRAF V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis
- (2018) Eli L. Diamond et al. JAMA Oncology
- Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults
- (2016) Xin-xin Cao et al. ANNALS OF HEMATOLOGY
- Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
- (2016) J.-F. Emile et al. BLOOD
- Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation
- (2014) B. Hervier et al. BLOOD
- Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation
- (2012) J. Haroche et al. BLOOD
- CNS involvement and treatment with interferon- are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients
- (2011) L. Arnaud et al. BLOOD
- Erdheim–Chester disease: Multisystem involvement and management with interferon-α
- (2009) Hiroshi I. Suzuki et al. LEUKEMIA RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search